Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06458985

Disclosure Intervention for People in Treatment for Opioid Use Disorder

The goal of this clinical trial is to test a disclosure intervention among people in treatment for opioid use disorder. The main question it aims to answer is whether people who receive a disclosure intervention have better treatment- and recovery-related outcomes one year after receiving the intervention. Participants will complete a brief disclosure intervention designed to help them (1) make key disclosures related to disclosure and (2) build skills to disclose. Researchers will compare results to participants in a waitlist comparator condition, who receive the intervention at the end of the study.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Opioid Use Disorder Behavior Chemically-Induced Disorders Mental Disorders Narcotic-Related Disorders Opioid-Related Disorders Social Behavior Social Isolation Social Stigma Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Brandywine Counseling & Community Services

Wilmington, Delaware, 19805, United States

Location status: Recruiting

Location contact

Carly Hill

CONTACT

[email protected]

1-302-401-1397‬

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Client of Brandywine Counseling & Community Services
  • Receiving opioid use disorder treatment at Brandywine Counseling & Community Services
  • Considering disclosing one's opioid use disorder history and/or treatment to someone new

Exclusion criteria

  • Diagnosis of schizophrenia
  • Participation in pilot study of intervention

Treatment and study plan

Disclosing Recovery: A Decision Aid and Toolkit

Behavioral

The Disclosing Recovery intervention is designed to help people in treatment for opioid use disorder (1) make key decisions regarding disclosure, including whether, why, what, how, and when to disclose, and (2) build skills to disclose, including planning what to say, practicing disclosure, and preparing for negative responses.

Other names: Disclosing Recovery

Primary outcomes

  1. Retention in treatment

    Time frame: 1 year

    Whether participants are retained in treatment 1 year after baseline

  2. Illicit opioid use

    Time frame: 1 year

    Percentages of drug screens that are positive for illicit opioid use

Secondary outcomes

  1. Recovery capital score

    Time frame: 1 year

    Average scores on recovery capital measure (titled: Brief Assessment of Recovery Capital); items are measured on a 1-5 point Likert-type scale, and composite scores range from 1-5. Higher values indicate greater recovery capital.

  2. Quality of life score

    Time frame: 1 year

    Average scores on quality of life measure (titled: European Health Interview Survey-Quality of Life - 8 item); items are measured on a 1-5 point Likert-type scale, and composite scores range from 1-5. Higher scores indicate greater quality of life.

Study contacts

Contact information is provided by the study sponsor or research team.

Valerie A Earnshaw, PhD

CONTACT

[email protected]

1-302-831-4772

Sponsors and collaborators

Lead sponsor

University of Delaware

Other

Collaborators

  • Brandywine Counseling and Community Services
  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Disclosure Intervention to Reduce Social Isolation and Facilitate Recovery Among People in Treatment for Opioid Use Disorder

Important dates

Study start
2024
Primary completion
2028
Study completion
2028
First posted
Jun 14, 2024
Registry last updated
Jul 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.